Syneron Medical Ltd. (NASDAQ: ELOS) has announced that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to market the UltraShape™ System for non-invasive reduction of abdominal circumference via fat

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In